Corcept Therapeutics Incorporated (CORT) — the earnings record
Computed on 2026-09-18 from the vendor's per-print history with the Print Record's method — no desk-written read yet. An investment research diary, not advice.
The record at a glance
Reactions across the covered prints span -6.8% to +21.4% — the beat column and the reaction column frequently disagree, which is the whole reason the record scores them separately. The street carries est EPS $0.81 · est revenue ~$0.32B into the next print.
Print by print
| Date | EPS | Revenue | |
|---|---|---|---|
| Jul 26 | 2026-07-29 | ✓ beat | ✓ beat |
| Apr 26 | 2026-04-30 | ✗ miss | ✗ miss |
| Feb 26 | 2026-02-24 | ✗ miss | ✗ miss |
| Nov 25 | 2025-11-04 | ✗ miss | ✗ miss |
| Jul 25 | 2025-07-31 | ✓ beat | ✗ miss |
| May 25 | 2025-05-05 | ✗ miss | ✗ miss |
| Feb 25 | 2025-02-26 | ✗ miss | ✗ miss |
| Oct 24 | 2024-10-30 | ✓ beat | ✗ miss |
| Jul 24 | 2024-07-29 | ✓ beat | ✓ beat |
| May 24 | 2024-05-01 | ✓ beat | ✓ beat |
Report-day close to the close three sessions later on adjusted closes, ±3% bands — the same method as every hand-written card; the Print Record method explains the bands. No reaction chart, metric line or behavior read exists for CORT yet.
FAQ · from the current data · as of 2026-09-18
Quick answers
How often does Corcept Therapeutics Incorporated beat earnings estimates?
Across the last 10 covered prints (as of the 2026-09-18 card), Corcept Therapeutics Incorporated beat EPS estimates 5 of 10 times and revenue estimates 3 of 10 times, with 3 double beats.
How does CORT stock react to earnings?
Measured close-of-print-day to the close three sessions later: 6 of the last 10 prints resolved up (beyond +3%), 2 flat, 2 down — reactions spanning -6.8% to +21.4%. Beat-or-miss and reaction are scored separately because they frequently disagree.
What was CORT's biggest earnings reaction?
+21.4% over the three sessions after the Jul 26 print (2026-07-29).
When does Corcept Therapeutics Incorporated report earnings next?
2026-11-04 (2026-11-04 · est EPS $0.81 · est revenue ~$0.32B). This record is computed from the vendor's per-print history with the Print Record's method; a desk-written card for CORT does not exist yet. An investment research diary, not advice.
Mentioned on Closelook
Where CORT appears in the diary — 1 piece, newest first. Every link is our own writing.
Go deeper
Dailies
- A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000
Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG…
Related in the Closelook universe
then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- BION.SW BB Biotech AGindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- ONC BeiGene, Ltd.industry
- REGN Regeneron Pharmaceuticals Incindustry
- UCB.BR UCB SAindustry
- MRNA Moderna Incindustry
- TWST Twist Bioscience Corpindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- SMMT Summit Therapeutics PLCindustry
- HALO Halozyme Therapeutics Incindustry
- TLX.AU TELIX Pharmaceuticals Ltdindustry
- SRPT Sarepta Therapeutics Incindustry
- GMAB Genmab ASindustry
- IBRX Immunitybio Incindustry
- CRSP Crispr Therapeutics AGindustry
- EXEL Exelixis Incindustry
- TGTX TG Therapeutics Incindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- INCY Incyte Corporationindustry